- Home
- EVC vs BIOA Comparison
EVC vs BIOA Comparison
Compare EVC & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVC
- BIOA
- Stock Information
- Founded
- EVC 1996
- BIOA 2015
- Country
- EVC United States
- BIOA United States
- Employees
- EVC N/A
- BIOA N/A
- Industry
- EVC Broadcasting
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- EVC Industrials
- BIOA Health Care
- Exchange
- EVC Nasdaq
- BIOA Nasdaq
- Market Cap
- EVC 166.5M
- BIOA 139.1M
- IPO Year
- EVC 2000
- BIOA 2024
- Fundamental
- Price
- EVC $1.88
- BIOA $3.87
- Analyst Decision
- EVC
- BIOA Hold
- Analyst Count
- EVC 0
- BIOA 4
- Target Price
- EVC N/A
- BIOA $5.67
- AVG Volume (30 Days)
- EVC 291.3K
- BIOA 365.5K
- Earning Date
- EVC 05-01-2025
- BIOA 05-15-2025
- Dividend Yield
- EVC 10.61%
- BIOA N/A
- EPS Growth
- EVC N/A
- BIOA N/A
- EPS
- EVC N/A
- BIOA N/A
- Revenue
- EVC $364,948,000.00
- BIOA N/A
- Revenue This Year
- EVC $64.06
- BIOA N/A
- Revenue Next Year
- EVC N/A
- BIOA N/A
- P/E Ratio
- EVC N/A
- BIOA N/A
- Revenue Growth
- EVC 22.86
- BIOA N/A
- 52 Week Low
- EVC $1.58
- BIOA $2.88
- 52 Week High
- EVC $2.73
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- EVC 42.54
- BIOA N/A
- Support Level
- EVC $1.81
- BIOA N/A
- Resistance Level
- EVC $1.92
- BIOA N/A
- Average True Range (ATR)
- EVC 0.11
- BIOA 0.00
- MACD
- EVC -0.01
- BIOA 0.00
- Stochastic Oscillator
- EVC 26.67
- BIOA 0.00
About EVC Entravision Communications Corporation
Entravision Communications Corp is a global advertising solutions, media, and technology company. Its operations encompass integrated marketing and media solutions, comprised of television, radio, and digital properties and data analytics services. The company operates in television broadcasting, audio broadcasting, and digital media segments. The Company's digital segment, whose operations are located in Europe, Latin America, Asia, the United States, and Africa. The Company's television and audio operations reach and engage U.S. Hispanics in the United States.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.